Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,921,000 | 2,802,000 | 3,130,000 | 3,044,000 | 2,988,249 |
| Marketable Securities | 87,000 | 23,000 | 128,000 | 121,000 | 119,470 |
| Receivables | 3,400,000 | 3,268,000 | 3,093,000 | 2,864,000 | 2,855,217 |
| Inventories | 1,385,000 | 1,365,000 | 1,393,000 | 1,630,000 | 1,342,035 |
| Other current assets | 166,000 | 264,000 | 234,000 | 168,000 | 144,586 |
| TOTAL | $7,959,000 | $7,722,000 | $7,978,000 | $7,827,000 | $7,449,557 |
| Non-Current Assets | |||||
| PPE Net | 2,464,000 | 1,563,000 | 1,710,000 | 1,706,000 | 1,667,927 |
| Investments And Advances | 724,000 | 767,000 | 666,000 | 577,000 | 762,430 |
| Intangibles | 9,229,000 | 5,906,000 | 5,942,000 | 5,025,000 | 4,065,855 |
| Other Non-Current Assets | 890,000 | 1,137,000 | 1,235,000 | 1,123,000 | 988,728 |
| TOTAL | $13,307,000 | $9,373,000 | $9,553,000 | $8,431,000 | $7,484,940 |
| Total Assets | $21,268,000 | $17,096,000 | $17,530,000 | $16,258,000 | $14,934,510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,578,000 | 1,669,000 | 1,329,000 | 1,632,000 | 1,506,940 |
| Other current liabilities | 2,542,000 | 2,512,000 | 2,339,000 | 1,813,000 | 1,751,167 |
| TOTAL | $7,328,000 | $4,483,000 | $3,978,000 | $3,570,000 | $3,430,880 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,859,000 | 1,229,000 | 872,000 | 853,000 | 1,046,198 |
| TOTAL | $2,113,000 | $1,276,000 | $1,587,000 | $1,332,000 | $1,052,191 |
| Total Liabilities | $9,440,000 | $5,759,000 | $5,565,000 | $4,903,000 | $4,483,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 1,977,450 | 2,531,500 | N/A |
| Common Shares | 945,000 | 928,000 | 972,000 | 920,000 | 854,908 |
| Retained earnings | 8,311,000 | 8,937,000 | 9,208,000 | 9,053,000 | 8,076,348 |
| Other shareholders' equity | 1,009,000 | 1,358,000 | 1,396,000 | 1,035,000 | 1,355,879 |
| TOTAL | $11,827,000 | $11,337,000 | $11,965,000 | $11,355,000 | $10,451,430 |
| Total Liabilities And Equity | $21,267,000 | $17,096,000 | $17,530,000 | $16,258,000 | $14,934,501 |